6Mladenovska K,Klisarova LJ,Kumbaradzi EF,et al.Crosslinkedgelatin microspheres containing BSA as a vaccine formulation:Biodegradation and drug release control in the presence of trypsin[J].Bull Chem Technol Macedonia,2001,20(2):151-156.
7Morimoto K,Katsumata H,Yabuta T,et al.Evaluation of gelatinmicrospheres for nasal and instramuscular administrations of salmoncalcitonin[J].Eur J Pharm Sci,2001,13(2):179-185.
8Vandelli MA,Rivasi F,Guerra P,et al.Gelatin microspherescrosslinked with D,L-glyceraldehyde as a potential drug deliverysystem:preparation,characterisation,in vitro and in vivo studies[J].Int J Pharm,2001,215(1-2):175-184.
9Nakaoka R,Tabata Y,Ikada Y.Potentiality of gelatin micro-spheres as immunological adjuvant[J].Vaccine,1995,13(7):653-661.
10Oe S,Fukunaka Y,Hirose T,et al.Atrial on regeneration ther-apy of rat liver cirrhosis by controlled release of hepatocytegrowth factor[J].J Control Release,2003,88(2):193-200.
